Teratomas are tumors that grow from germ cells and can contain a startling mix of tissue types, including hair, teeth, bone, and fully formed brain tissue. When brain-like (neural) elements appear inside a teratoma, the medical concern is twofold: the tumor itself needs to be managed, and the neural tissue can sometimes provoke a dangerous autoimmune attack on the patient’s actual brain. That autoimmune complication, called anti-NMDA receptor encephalitis, is the reason teratomas with brain tissue have drawn so much attention over the past two decades.
How Common Is Brain Tissue in Teratomas
Teratomas arise from germ cells capable of developing into any body tissue. The ovary is the most common site, but teratomas also appear in the tailbone area, the chest cavity, the space behind the abdomen, and inside the skull itself.1PubMed Central. A visual compendium of teratomas and their diverse anatomical locations Most ovarian teratomas are “mature,” meaning they contain well-differentiated adult-type tissue and behave in a benign fashion. A smaller fraction are “immature,” with primitive embryonic tissue that carries a risk of malignancy.
Neural elements turn up in a meaningful share of these tumors. An eleven-year study from India examining mature ovarian teratomas found neural components, including glial tissue, ganglion cells, and even recognizable cerebellar structures, in roughly a quarter of cases.2PubMed Central. Types and Frequency of Neural Elements in Mature Ovarian Teratomas: An 11-Year Study from Rural India A separate neuropathological study that examined over a hundred resected ovarian teratomas found that the central nervous system tissue inside them often formed thin, undulating structures lining cyst walls, complete with neurons, astrocytes, ependymal cells, and even choroid plexus (the tissue that produces cerebrospinal fluid in a real brain).3PubMed. Central nervous tissue in ovarian mature teratoma: A neuropathological study of 101 resected tumors In short, brain tissue inside a teratoma is not some freakish rarity. It is an established, well-documented feature of these tumors.
What Brain Tissue Inside a Teratoma Looks Like Under the Microscope
The neural tissue inside teratomas is not just random clumps of nerve cells. It can be remarkably organized, sometimes mimicking real brain architecture. Neuropathological analysis has shown that some ovarian teratomas form cerebral cortex-like structures with visible “gyration,” the folds you see on the surface of a normal brain, although the layers are incomplete and disorganized. Purkinje cells, the large distinctive neurons of the cerebellum, have been identified with varied structural abnormalities. Astrocytes in these tumors sometimes wrap around capillary walls the way they do in a living brain, forming something that resembles a blood-brain barrier.3PubMed. Central nervous tissue in ovarian mature teratoma: A neuropathological study of 101 resected tumors
Despite the architectural sophistication, these neurons are usually abnormal. In teratomas linked to autoimmune encephalitis, researchers have found mature but dysplastic neurons with two or more nuclei per cell, an abnormal shape, and a tendency to cluster. If those same neurons were found growing inside a person’s actual brain, pathologists would classify them as a type of brain tumor called a ganglioglioma.4JAMA Neurology. Abnormal Neurons in Teratomas in NMDAR Encephalitis In immature teratomas, the neural component is more primitive, featuring neuroblasts (immature nerve cell precursors) with high rates of cell division. Distinguishing immature from mature neural tissue in a teratoma has real consequences for treatment, because immature teratomas may require chemotherapy while mature ones generally do not.
How Pathologists Tell Immature From Mature Neural Tissue
Getting this distinction right is harder than it sounds. Immature teratomas have significantly higher rates of cell proliferation, mitotic activity, and necrosis in their neural tissue compared with mature teratomas.5PubMed Central. Diagnostic Significance of Cellular Neuroglial Tissue in Ovarian Immature Teratoma But certain architectural features can fool pathologists. A marker called SOX2, for example, is sometimes used to flag immature neural tissue, yet it lights up in both immature and mature elements like glia and ependymal structures. In one study, systematic re-examination prompted by ambiguous SOX2 staining led to the reclassification of over half of cases initially diagnosed as immature teratoma to mature teratoma instead.6PubMed. Pattern-based interpretation of SOX2 expression in ovarian teratomas: avoiding diagnostic pitfalls in the distinction between immature and mature neuroectodermal elements That kind of misclassification matters because it can mean the difference between surgery alone and unnecessary chemotherapy.
When Brain Tissue in a Teratoma Triggers Autoimmune Encephalitis
The most dramatic symptom scenario involving teratomas with brain tissue is anti-NMDA receptor encephalitis. The mechanism works like this: neurons inside the teratoma express NMDA receptors, the same receptors found on nerve cells throughout the brain. The immune system detects these receptors as foreign, mounts an antibody response, and those antibodies then cross-react with NMDA receptors in the patient’s actual brain, producing severe neurological and psychiatric symptoms.
Studies have confirmed that teratomas from patients with encephalitis contain neural tissue with unusually intense expression of the NMDA receptor subunit NR1, surrounded by dense infiltration of immune cells that organize into lymphoid follicle-like structures right inside the tumor.7Clinical Immunology. Clinicopathological characteristics of dysplastic teratomous neuroglia with anti-N-methyl-d-aspartate receptor encephalitis Research published in Brain went further, demonstrating that these intratumoral immune structures function as active antibody factories, producing NMDA receptor antibodies on-site. The same study found that cervical lymph nodes also serve as production sites, which helps explain why symptoms sometimes persist after tumor removal.8Brain. Cervical lymph nodes and ovarian teratomas as germinal centres in NMDA receptor-antibody encephalitis
Recognizing the Symptoms
Anti-NMDA receptor encephalitis typically unfolds in stages. It often starts with a flu-like prodrome lasting up to two weeks, with symptoms like fatigue, low-grade fever, headache, nausea, or upper respiratory complaints. More than half of patients in one systematic review experienced this initial viral-illness mimic before psychiatric symptoms appeared.9PubMed Central. Patterns of Neuropsychiatric Manifestations of Ovarian Teratomas: A Systematic Review of Case Reports
After the prodrome, the disease enters a psychotic phase. The most commonly reported symptoms in case series are memory problems (about half of patients), hallucinations (around 43%), and aggressive behavior (roughly 40%).9PubMed Central. Patterns of Neuropsychiatric Manifestations of Ovarian Teratomas: A Systematic Review of Case Reports The psychiatric features can closely mimic schizophrenia, with delusions, disorganized thinking, and perceptual disturbances appearing without obvious neurological signs at first. This phase typically lasts one to three weeks before the condition progresses to more overtly neurological territory: patients may become mute, unresponsive, and develop involuntary movements of the face and limbs, along with autonomic instability like wildly fluctuating heart rate and blood pressure.10PubMed Central. Fulminant course in a patient with anti-N-methyl-d-aspartate receptor encephalitis with bilateral ovarian teratomas
A meta-analysis of reported cases found that psychosis, seizures, dangerously slowed breathing, loss of speech, and coma all occurred at rates far higher than expected in the general population among patients with ovarian teratoma-associated anti-NMDAR encephalitis.11Heliyon. Ovarian teratoma-associated Anti-NMDAR encephalitis in women with first-time neuropsychiatric symptoms: A meta-analysis and systematic review of reported cases The hallmark of the disease, and the clue that sets it apart from a primary psychiatric disorder, is that conventional psychiatric medications do not work. In one review, over 90% of patients failed to respond to antipsychotics and other standard psychiatric treatments.9PubMed Central. Patterns of Neuropsychiatric Manifestations of Ovarian Teratomas: A Systematic Review of Case Reports
Why This Gets Misdiagnosed
Misdiagnosis is the norm early on. Because the psychiatric symptoms appear before anyone suspects a tumor, young women with anti-NMDAR encephalitis are frequently admitted to psychiatric units with a working diagnosis of acute psychosis, new-onset schizophrenia, or a drug reaction. The neuropsychiatric symptoms almost always precede the teratoma diagnosis, with one review finding that this was the case in 98% of patients.9PubMed Central. Patterns of Neuropsychiatric Manifestations of Ovarian Teratomas: A Systematic Review of Case Reports The condition mimics psychiatric and infectious diseases closely enough to delay correct diagnosis by weeks or longer.12PubMed Central. Mind in Crisis, Ovary in Question: A Case of Anti-N-Methyl-D-Aspartate (NMDA) Receptor Encephalitis Associated With Ovarian Teratoma The turning point is usually the failure of psychiatric medication combined with the emergence of neurological signs like seizures or movement disorders, which prompts antibody testing.
A potentially useful diagnostic aid is testing cerebrospinal fluid for a specific antibody subtype. Patients whose spinal fluid contains IgA-class NMDA receptor antibodies have a much higher likelihood of harboring an ovarian teratoma. In adult women, this test showed 85% sensitivity and 90% negative predictive value for the presence of an ovarian teratoma, meaning a negative result is fairly reassuring that no tumor is there.13PubMed Central. CSF IgA NMDAR antibodies are potential biomarkers for teratomas in anti-NMDAR encephalitis
Treatment of the Teratoma
Surgery is the foundation. For ovarian teratomas, the standard operation is removal of the cyst while preserving as much healthy ovarian tissue as possible. Laparoscopic approaches, including single-incision techniques, are now the dominant method.14PubMed Central. Comparison between Laparoendoscopic Single-Site and Conventional Laparoscopic Surgery in Mature Cystic Teratoma of the Ovary For teratomas in other locations, the surgical approach varies. Sacrococcygeal teratomas in newborns, for instance, require complete excision along with removal of the coccyx (tailbone) to reduce recurrence.15PubMed Central. Neonatal sacrococcygeal teratoma: our experience with 10 cases
Whether chemotherapy is needed depends on the maturity and stage of the tumor. For immature teratomas in adults, platinum-based chemotherapy (a combination of bleomycin, etoposide, and cisplatin) is typically added after surgery.16PubMed Central. Immature Teratoma: Diagnosis and Management—A Review of the Literature In children, the picture is different. A large international collaborative analysis found that postoperative chemotherapy did not decrease relapses in pediatric patients with immature ovarian teratomas. Children treated with surgery alone had a five-year event-free survival of 91% and overall survival of 99%.17PubMed Central. Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the Malignant Germ Cell Tumor International Collaborative The role of chemotherapy in adults remains an open question, though current practice leans toward using it for higher-grade disease.
Treating Anti-NMDAR Encephalitis
When the teratoma has triggered autoimmune encephalitis, treatment has two equally urgent tracks: removing the tumor and calming the immune system. Prompt tumor resection is critical, as the research on intratumoral antibody production supports the clinical observation that patients improve faster when the tumor is taken out early.8Brain. Cervical lymph nodes and ovarian teratomas as germinal centres in NMDA receptor-antibody encephalitis
First-line immunotherapy typically includes high-dose corticosteroids, intravenous immunoglobulin, and plasma exchange (plasmapheresis). These treatments can begin to improve symptoms within about four weeks.18Journal of Yeungnam Science. Anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma in Korea: three case reports Patients who do not respond to first-line therapy may be escalated to second-line agents, most commonly rituximab (which depletes antibody-producing B cells) or cyclophosphamide. Published case reports describe patients receiving all of these in combination when the disease is severe.19Case Reports in Women’s Health. Anti-NMDA encephalitis secondary to an ovarian teratoma presenting as altered mental status in a 32-year-old woman: A case report Recovery can be slow, stretching over months, and some patients experience long-lasting cognitive effects even after the acute illness resolves.
Intracranial Teratomas and Their Own Set of Challenges
Sometimes the teratoma is not in the ovary provoking brain inflammation from a distance; it is growing inside the skull itself. Intracranial teratomas are rare and occur most often in children and young adults. On MRI, they appear as irregularly shaped masses with mixed signals reflecting their hodgepodge of tissue contents: fat, calcium, fibrous tissue, cysts, and keratin.20PubMed. Imaging characteristics of primary intracranial teratoma Biochemical markers and tissue analysis after surgery are needed to confirm the diagnosis.21PubMed Central. Intracranial Mature Teratoma in an Adult Patient: A Case Report
Symptoms of an intracranial teratoma depend on its location and size but commonly include headache from increased pressure inside the skull, vision changes, hormonal disruptions (particularly when tumors sit near the pituitary gland), nausea, and balance problems. Treatment centers on surgical removal. In a study of 31 patients with primary intracranial teratomas, those who had complete surgical removal fared well regardless of whether additional chemotherapy or radiation was given, with a five-year survival rate of 74%.22PubMed. Treatment and outcomes of primary intracranial teratoma A more recent single-institution pediatric series reported excellent prognoses when gross total resection was achieved alongside chemotherapy and radiation, with no recurrence over a median follow-up of nearly five years.23Pediatric Neurosurgery. Treatment Course and Outcomes of Intracranial Teratomas in Pediatric Patients: A Retrospective 15-Year Case Series Study
A peculiar complication of intracranial germ cell tumors is “growing teratoma syndrome,” where a tumor paradoxically enlarges during or after chemotherapy despite normalizing tumor markers. This is not a sign of treatment failure in the usual sense; instead, the chemotherapy has killed the malignant component while the mature teratoma tissue continues to grow. In one study, about 6.5% of intracranial germ cell tumor patients developed this syndrome, and nearly all showed a characteristic honeycomb-shaped multicystic pattern on MRI. Complete surgical removal was curative in most cases, while patients with residual masses did poorly.24PubMed. Intracranial growing teratoma syndrome: clinical characteristics and treatment strategy
Gliomatosis Peritonei
Another unusual complication involving neural tissue and teratomas is gliomatosis peritonei, a condition where mature glial (brain-support) tissue implants spread across the lining of the abdomen. This condition typically accompanies immature ovarian teratomas and can look alarming on imaging, sometimes mimicking the appearance of widespread cancer.25PubMed Central. Gliomatosis Peritonei and Its Relation to Teratoma: Role of Imaging and Histological Aspects A biopsy is needed to confirm that the implants are composed of benign mature glial tissue rather than tumor spread.
The origin of these implants has been debated. One prominent theory is that the glial tissue breaks off from the teratoma and seeds the peritoneum. But genetic analysis has pointed to a different explanation: the implants often arise from the patient’s own peritoneal cells, which undergo a transformation into glial tissue independently of the tumor.26PubMed Central. Glial implants in gliomatosis peritonei arise from normal tissue, not from the associated teratoma Despite its frightening appearance, the condition generally has a good prognosis. An international multicenter series of 23 patients found that all remained alive over a median follow-up of nearly seven years, even though roughly half eventually relapsed. Relapses rarely contained immature teratoma components, and fertility-sparing surgery was performed in the majority of patients.27PubMed. Gliomatosis peritonei with ovarian teratoma: an international multicenter case series
Fertility After Ovarian Teratoma Treatment
Because ovarian teratomas disproportionately affect women of reproductive age, fertility preservation is a central concern. Surgeons now strongly favor fertility-sparing approaches, removing the affected ovary (or just the cyst) while leaving the uterus and opposite ovary intact. Among patients with advanced-stage ovarian immature teratomas who underwent fertility-sparing surgery, about 46% became pregnant afterward, with most conceptions occurring spontaneously.28PubMed Central. Oncologic and fertility outcome in patients with advanced stage ovarian immature teratomas That is encouraging, though patients who require chemotherapy may face additional effects on ovarian function that should be discussed before treatment starts.
Teratoma-Derived Brain Tissue in Laboratory Research
The ability of teratomas to spontaneously generate organized brain tissue has not been lost on researchers looking for new ways to study neurological diseases. Scientists have exploited the natural tendency of embryonic stem cells to form teratomas in living hosts, then harvested the early neural cells from those teratomas and cultured them into brain organoids in the lab. These organoids developed recognizable brain-like structures, including ventricle-like cavities and layered cortical tissue, within three weeks of culture.29PubMed. Generation of brain organoids from mouse ESCs via teratoma formation The approach is still experimental and has been done in mice, but it represents a creative use of the same biological quirk that makes teratomas so medically interesting: their ability to build complex tissues from scratch. Whether this platform becomes practical for modeling human brain diseases remains to be seen, but it highlights how the unsettling biology of teratomas is being repurposed into something potentially useful.